217 related articles for article (PubMed ID: 25246891)
1. Correlation of biochemical markers and clinical signs of hyperandrogenism in women with polycystic ovary syndrome (PCOS) and women with non-classic congenital adrenal hyperplasia (NCAH).
Chanukvadze D; Kristesashvili J; Kvashilava N
Iran J Reprod Med; 2012 Jul; 10(4):307-14. PubMed ID: 25246891
[TBL] [Abstract][Full Text] [Related]
2. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
[TBL] [Abstract][Full Text] [Related]
3. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
Nadaraja RND; Sthaneshwar P; Razali N
Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
[TBL] [Abstract][Full Text] [Related]
4. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome.
Pignatelli D
Front Horm Res; 2013; 40():158-70. PubMed ID: 24002412
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women.
Fanta M; Cibula D; Vrbíková J
Gynecol Endocrinol; 2008 Mar; 24(3):154-7. PubMed ID: 18335331
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
[TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
8. [Correlations between clinical signs and hormonal parameters in young women with hirsutism].
Kristesashvili J; Chanukvadze D
Georgian Med News; 2011 Nov; 11(200):30-5. PubMed ID: 22201077
[TBL] [Abstract][Full Text] [Related]
9. Endocrinological markers for assessment of hyperandrogenemia in hirsute women.
Mueller A; Cupisti S; Binder H; Hoffmann I; Kiesewetter F; Beckmann MW; Dittrich R
Horm Res; 2007; 67(1):35-41. PubMed ID: 17019078
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
Hahn S; Kuehnel W; Tan S; Kramer K; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
Clin Chem Lab Med; 2007; 45(2):202-7. PubMed ID: 17311509
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
[TBL] [Abstract][Full Text] [Related]
12. Comparison Of Free Androgen Index In Polycystic Ovary Syndrome And Non-Polycystic Ovary Syndrome Infertile Patients.
Khattak M; Usman R; Sultana N; Khattak A
J Ayub Med Coll Abbottabad; 2021; 33(4):577-581. PubMed ID: 35124911
[TBL] [Abstract][Full Text] [Related]
13. Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism.
Al Kindi MK; Al Essry FS; Al Essry FS; Mula-Abed WA
Oman Med J; 2012 Nov; 27(6):471-4. PubMed ID: 23226817
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study.
Yuan C; Liu X; Mao Y; Diao F; Cui Y; Liu J
J Biomed Res; 2016 May; 30(3):197-202. PubMed ID: 27526961
[TBL] [Abstract][Full Text] [Related]
15. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
16. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
[TBL] [Abstract][Full Text] [Related]
17. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.
Carmina E; Dewailly D; Escobar-Morreale HF; Kelestimur F; Moran C; Oberfield S; Witchel SF; Azziz R
Hum Reprod Update; 2017 Sep; 23(5):580-599. PubMed ID: 28582566
[TBL] [Abstract][Full Text] [Related]
18. A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue.
Unluhizarci K; Gokce C; Atmaca H; Bayram F; Kelestimur F
Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):504-9. PubMed ID: 15505757
[TBL] [Abstract][Full Text] [Related]
19. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
20. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
